AngioDynamics (ANGO) Stock Price, News, Quotes-Moomoo

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

ANGO AngioDynamics

Watchlist

12.940
+3.540+37.66%

Close Jan 8 16:00 ET

13.010
+0.070+0.54%

Post 20:01 ET

523.63MMarket Cap-2.31P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | AngioDynamics Inc : Canaccord Genuity Raises Target Price to $15 From $12
Reuters3minutes ago
Q2 2025 AngioDynamics Inc Earnings Call
Yahoo Finance00:31 ET
AngioDynamics | 10-Q: Quarterly report
SEC14:09 ET · Announcements
Crude Oil Down 1%; US Weekly Jobless Claims Decline
Benzinga12:09 ET
Earnings Call Summary | AngioDynamics(ANGO.US) Q2 2025 Earnings Conference
moomoo AI11:02 ET · Conference Call
AAR Posts Upbeat Results, Joins AngioDynamics, EBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday
BenzingaJan 8 10:07 ET

Comments

Trytosaveabit

Dec 9, 2024 12:42

$AngioDynamics (ANGO.US)$ Not to shabby! Lets try to push for a NHOD? Hehehe

Trytosaveabit

Dec 9, 2024 05:04

News

$AngioDynamics (ANGO.US)$ The FDA Has Granted 510(k) Clearance For AngioDynamics' Nanoknife System For Prostate Tissue Ablation
Benzinga· 1 min ago

Jaguar8

Dec 9, 2024 05:01

NEWS

$AngioDynamics (ANGO.US)$
AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation
AngioDynamics, Inc. (NASDAQ:ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving patient quality of life, today announced it received U.S. Food and Drug Administration (FDA) 510(k) clearance for the NanoKnife System for prostate tissue ablation.
Th...

Trytosaveabit

Oct 23, 2024 07:15

Update

$AngioDynamics (ANGO.US)$ Benzinga· 1 min ago
AngioDynamics, University College London Hospital Launch International Multi-Center Study On Long Term Effects Of Treatment With NanoKnife System

Jaguar8

Sep 19, 2024 15:48

NEWS

$AngioDynamics (ANGO.US)$
AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes
AngioDynamics, Inc. (NASDAQ: ANGO) has launched the RECOVER-AV clinical trial to evaluate the AlphaVac F18⁸⁵ System for treating acute, intermediate-risk pulmonary embolism (PE) in the European market.
This multi-center, multi-national study follows the successful APEX-AV trial in the US, which showed significant impr...

Heat List

Overall

No Data